Categories AlphaGraphs, Earnings, Health Care
Trxade Health (MEDS) reports 20% growth in Q4 revenue; results beat estimates
Trxade Health Inc (NASDAQ: MEDS) Monday reported a narrower net loss for the fourth quarter of 2021 as the pharmaceutical services company’s revenues increased 20%.
Fourth-quarter revenues increased 19.7% year-over-year to $2.4 million and came in above analysts’ estimates. The company added 175 registered members during the three-month period.
Trxade reported a net loss of $0.8 million or $0.10 per share for the fourth quarter, which marked an improvement from the $2.3 million or $0.29 per share loss reported in the year-ago quarter. The bottom line also beat analysts’ estimates.
Check this space to read management/analysts’ comments on Trxade’s Q4 2021 results
Shares of Trxade closed Monday’s trading higher and continued to gain in the extended session, soon after the earnings announcement. The stock has lost about 55% in the past six months.
Prior Performance
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
